Related Experiment Video
Updated: Jun 14, 2026

08:14
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
Low-penetrance susceptibility to hematological malignancy
1Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK. Richard.houlston@icr.ac.uk
Current Opinion in Genetics & Development
|April 13, 2010
Summary
Genome-wide association studies are revealing inherited genetic factors for cancer susceptibility. These studies are advancing our understanding of chronic lymphocytic leukemia and acute lymphoblastic leukemia.
Area of Science:
- Genetics
- Oncology
- Genomics
Background:
- Increasing evidence suggests inherited genetic factors contribute to cancer susceptibility.
- This susceptibility is often linked to the combined effect of multiple low-risk genetic variants (alleles).
Purpose of the Study:
- To discuss the impact of genome-wide association studies (GWAS) on understanding cancer genetics.
- To explore the application of GWAS in two major hematological malignancies: chronic lymphocytic leukemia and acute lymphoblastic leukemia.
Main Methods:
- Genome-wide association studies (GWAS) enable the search for susceptibility alleles across the entire genome.
- Analysis of genetic data to identify common variants associated with disease risk.
Main Results:
- GWAS are significantly enhancing the identification of genetic susceptibility loci for complex diseases.
- These studies are providing new insights into the genetic architecture of hematological malignancies.
Conclusions:
- Genome-wide association studies are a powerful tool for dissecting the genetic basis of cancer.
- The application of GWAS is crucial for understanding the inherited components of chronic lymphocytic leukemia and acute lymphoblastic leukemia.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Lineage Commitment
Commitment is the process whereby stem cells:
